Nektar Therapeutics | NKTR - Current Liabilities


Nektar Therapeutics reported $53.54M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agios Pharmaceuticals USD 58.84M 23.36M Mar/2026
ALKERMES USD 599.5M 56.06M Mar/2026
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 24.96B 534M Mar/2026
Baxter International USD 3.69B 723M Mar/2026
BioCryst Pharmaceuticals USD 196.07M 5.83M Dec/2025
Biogen USD 3B 350.5M Mar/2026
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Cara Therapeutics USD 11.04M 362K Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Dr.Reddys Laboratories INR 158.31B 7.38B Dec/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 36.63B 1.41B Mar/2026
Esperion Therapeutics USD 300.81M 58.22M Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Grifols EUR 2.37B 156.97M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Incyte USD 1.49B 25.52M Mar/2026
Ionis Pharmaceuticals USD 717M 66M Mar/2026
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
MacroGenics USD 43.11M 1.36M Dec/2025
Merck USD 26.94B 1.38B Mar/2026
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Neurocrine Biosciences USD 831.7M 88.3M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sarepta Therapeutics USD 1.1B 173.86M Dec/2025
Takeda JPY 2.61T 470.53B Dec/2025
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026
Xencor USD 95.91M 9.42M Dec/2025